PMV Pharmaceuticals, Inc. (PMVP) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 294 transactions totaling $134.3M, demonstrating a bullish sentiment with $10.4M in net insider flow. The most recent transaction on Oct 27, 2025 involved a transaction of 220,643 shares valued at $302.3K.
No significant insider buying has been recorded for PMVP in the recent period.
No significant insider selling has been recorded for PMVP in the recent period.
Based on recent SEC filings, insider sentiment for PMVP is bullish with an Insider Alignment Score of 54/100 and a net flow of $10.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at PMV Pharmaceuticals, Inc. (PMVP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading PMVP stock, having executed 294 transactions in the past 90 days. The most active insider is Thilo Schroeder (Executive), who has made 99 transactions totaling $38.3M.
Get notified when executives and directors at PMVP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | Henry Mack David | Executive | Option Exercise | 220,643 | $1.37 | $302.3K | |
| Oct 23, 2025 | Gp V. Llc Orbimed Capital | Executive | Sale | 1,000,000 | $1.52 | $1.5M | Large |
| Sep 10, 2025 | Llc Orbimed Advisors | Executive | Sale | 500,000 | $1.80 | $900.0K | Large |
| Jul 1, 2025 | Henry Mack David | Executive | Sale | 58,411 | $1.06 | $61.9K | |
| Jul 1, 2025 | Carulli Michael | Executive | Sale | 28,249 | $1.06 | $29.9K | |
| Jul 1, 2025 | Jalota Deepika | Executive | Sale | 33,065 | $1.06 | $35.0K | |
| Jul 1, 2025 | Ticktin Robert | Executive | Sale | 23,151 | $1.06 | $24.5K | |
| Sep 11, 2024 | Carulli Michael | Executive | Sale | 2,891 | $1.50 | $4.3K | |
| Sep 11, 2024 | Jalota Deepika | Executive | Sale | 7,218 | $1.50 | $10.8K | |
| Jan 18, 2024 | Henry Mack David | Executive | Award | 163,890 | $N/A | $0 | |
| Jan 18, 2024 | Carulli Michael | Executive | Award | 82,220 | $N/A | $0 | |
| Jan 18, 2024 | Jalota Deepika | Executive | Award | 95,555 | $N/A | $0 | |
| Nov 22, 2023 | Gp Llc Orbimed Genesis | Executive | Sale | 87,786 | $2.23 | $195.8K | |
| Nov 10, 2023 | Henry Mack David | Executive | Gift | 85,307 | $N/A | $0 | |
| Nov 10, 2023 | Henry Mack David | Executive | Gift | 85,307 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 10 | $72.4M | 53.2% |
Sale(S) | 181 | $61.9M | 45.5% |
Exercise(M) | 32 | $1.7M | 1.2% |
Award(A) | 5 | $0 | 0.0% |
Gift(G) | 8 | $0 | 0.0% |
Other(J) | 18 | $0 | 0.0% |
Conversion(C) | 40 | $0 | 0.0% |
Insider activity at PMV Pharmaceuticals, Inc. shows mixed signals across all time. While $72.4M in purchases indicates some executive confidence,$61.9M in sales balances the picture, resulting in a modest net flow of $10.4M.26 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Thilo Schroeder, has transacted $38.3M during this period.